Identification of 27 5′ CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers

Oncogene

Volumn 23, Issue 53, 2004, Pages 8705-8710

  Hagihara, Atsushi ^a,b   Miyamoto, Kazuaki ^a   Furuta, Junichi ^a   Hiraoka, Nobuyoshi ^a   Wakazono, Kuniko ^a   Seki, Shuichi ^b   Fukushima, Shoji ^b   Tsao, Ming Sound ^c   Sugimura, Takashi ^a   Ushijima, Toshikazu ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

CpG island; Methylation; Pancreatic cancer; Silencing

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA FRAGMENT;

ADAM23 GENE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CDH2 GENE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; EGR4 GENE; EPIGENETICS; FBN2 GENE; GENE; GENE EXPRESSION; GENE ISOLATION; GENE SILENCING; GENETIC ANALYSIS; GENETIC DIFFERENCE; GENOME; GENOME SCANNING TECHNIQUE; HAND1 GENE; HUMAN; HUMAN TISSUE; METHYLATION SENSITIVE REPRESENTATIONAL DIFFERENCE ANALYSIS; METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; NEF3 GENE; NKX2 8 GENE; NPTX1 GENE; NTSR1 GENE; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PANCREAS DUCT; PANCREATIC DUCTAL EPITHELIAL CELL; POLYMERASE CHAIN REACTION; PRG2 GENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RASGRF2 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THBD GENE; TLL1 GENE;

CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE PROGRESSION; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; PANCREATIC NEOPLASMS; PHYSICAL CHROMOSOME MAPPING;

EID: 4644284196     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207783     Document Type: Article

References (36)

1. Agathanggelou A, Bieche I, Ahmed-Choudhury J, Nicke B, Dammann R, Baksh S, Gao B, Minna JD, Downward J, Maher ER and Latif F. (2003). Cancer Res., 63, 5344-5351.
2. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N and Perucho M. (1988). Cell, 53, 549-554.
3. Arozarena I, Matallanas D, Berciano MT, Sanz-Moreno V, Calvo F, Munoz MT, Egea G, Lafarga M and Crespo P. (2004). Mol. Cell. Biol., 24, 1516-1530.
4. Asada K, Miyamoto K, Fukutomi T, Tsuda H, Yagi Y, Wakazono K, Oishi S, Fukui H, Sugimura T and Ushijima T. (2003). Oncology, 64, 380-388.
5. Bardeesy N and DePinho RA. (2002). Nat. Rev. Cancer, 2, 897-909.
6. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ and Kern SE. (1994). Nat. Genet., 8, 27-32.
7. Clark TG, Conway SJ, Scott IC, Labosky PA, Winnier G, Bundy J, Hogan BL and Greenspan DS. (1999). Development, 126, 2631-2642.
8. Costa FF, Verbisck NV, Salim AC, Ierardi DF, Pires LC, Sasahara RM, Sogayar MC, Zanata SM, Mackay A, O'Hare M, Soares F, Simpson AJ and Camargo AA. (2004). Oncogene, 23, 1481-1488.
9. Furukawa T, Duguid WP, Rosenberg L, Viallet J, Galloway DA and Tsao MS. (1996). Am. J. Pathol., 148, 1763-1770.
10. Griffin CA, Hruban RH, Long PP, Morsberger LA, Douna-Issa F and Yeo CJ. (1994). Genes Chromosomes Cancer, 9, 93-100.
11. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, Da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH and Kern SE. (1996). Science, 271, 350-353.
12. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D and Baylin SB. (1995). Cancer Res., 55, 4525-4530.
13. Horikoshi N, Cong J, Kley N and Shenk T. (1999). Biochem. Biophys. Res. Commun., 261, 864-869.
14. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E and Thun MJ. (2003). CA Cancer J. Clin., 53, 5-26.
15. Julien JP and Mushynski WE. (1998). Prog. Nucleic Acid Res. Mol. Biol., 61, 1-23.
16. Kaneda A, Kaminishi M, Yanagihara K, Sugimura T and Ushijima T. (2002). Cancer Res., 62, 6645-6650.
17. Kaneda A, Takai D, Kaminishi M, Okochi E and Ushijima T. (2003). Ann. NY Acad. Sci., 983, 131-141.
18. Lisitsyn N and Wigler M. (1993). Science, 259, 946-951.
19. Liu N, Furukawa T, Kobari M and Tsao MS. (1998). Am. J. Pathol., 153, 263-269.
20. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D. (1995). Nat. Med., 1, 686-692.
21. Mitchell MS, Kan-Mitchell J, Minev B, Edman C and Deans RJ. (2000). Cancer Res., 60, 6448-6456.
22. Miyamoto K, Asada K, Fukutomi T, Okochi E, Yagi Y, Hasegawa T, Asahara T, Sugimura T and Ushijima T. (2003). Oncogene, 22, 274-280.
23. Omeis IA, Hsu YC and Perin MS. (1996). Genomics, 36, 543-545.
24. Paz MF, Wei S, Cigudosa JC, Rodriguez-Perales S, Peinado MA, Huang TH and Esteller M. (2003). Hum. Mol. Genet., 12, 2209-2219.
25. Qiu C, Yu M, Shan L and Snyderwine EG. (2003). Oncogene, 22, 1253-1260.
26. Riley P, Anson-Cartwright L and Cross JC. (1998). Nat. Genet., 18, 271-275.
27. Rozenblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M, Goodman SN, Sohn TA, Hruban RH, Yeo CJ and Kern SE. (1997). Cancer Res., 57, 1731-1734.
28. Sato N, Fukushima N, Maitra A, Matsubayashi H, Yeo CJ, Cameron JL, Hruban RH and Goggins M. (2003). Cancer Res., 63, 3735-3742.
29. Takai D and Jones PA. (2002). Proc. Natl. Acad. Sci. USA, 99, 3740-3745.
30. Takai D, Yagi Y, Wakazono K, Ohishi N, Morita Y, Sugimura T and Ushijima T. (2001). Oncogene, 20, 7505-7513.
31. Tourtellotte WG, Nagarajan R, Auyeung A, Mueller C and Milbrandt J. (1999). Development, 126, 5061-5071.
32. Toyota M, Ho C, Ahuja N, Jair KW, Li Q, Ohe-Toyota M, Baylin SB and Issa JP. (1999). Cancer Res., 59, 2307-2312.
33. Ueki T, Toyota M, Skinner H, Walter KM, Yeo CJ, Issa JP, Hruban RH and Goggins M. (2001). Cancer Res., 61, 8540-8546.
34. Ueki T, Toyota M, Sohn T, Yeo CJ, Issa JP, Hruban RH and Goggins M. (2000). Cancer Res., 60, 1835-1839.
35. Ushijima T, Morimura K, Hosoya Y, Okonogi H, Tatematsu M, Sugimura T and Nagao M. (1997). Proc. Natl. Acad. Sci. USA, 94, 2284-2289.
36. Wilentz RE, Iacobuzio-Donahue CA, Argani P, McCarthy DM, Parsons JL, Yeo CJ, Kern SE and Hruban RH. (2000). Cancer Res., 60, 2002-2006.